Suche   Â
DGAP-News: MPH Mittelständische Pharma Holding AG:
ID: 471155
(firmenpresse) - DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): Half
Year Results/Development of Sales
MPH Mittelständische Pharma Holding AG:
31.08.2011 / 13:18
---------------------------------------------------------------------
MPH Mittelständische Pharma Holding AG:
Half-year report 2011 now available
Compared to the same period of the previous year the turnover increased in
the first half of the year 2011 by +28% and reached 70.27 Mill.
The achieved EBIT margin was 8.7%. A net profit/share of 13 Cent was
earned.
The company MPH Mittelständische Pharma Holding AG today presents the
semi-annual report for the first six months of 2011.
During the first six months of 2011 the MPH corporation achieved a turnover
to the amount of 70.27 Mill. Euro and a period surplus to the amount of
5.03 Mill. Euro. The earnings before interest and taxes (EBIT) was 6.11
Mill. Euro. The earnings before interest, taxes, depreciation and
amortisation (EBITDA) was 6.53 Mill. Euro.
An increasing number of pharmacists, doctors and patients are placing their
trust in medications that are being made available by the MPH group in the
therapeutic areas oncology, HIV, rheumatology, neurology and cardiovascular
diseases.
The corporate group is therefore also for the current business year 2011
anticipating a continued growth in turnover and earnings.
About the company MPH Mittelständische Pharma Holding AG:
The Berlin based company MPH Mittelständische Pharma Holding AG has
strategically concentrated its activities on growth segments in the
pharmaceutical market. With pharmaceutical products based on patent-free
and patent-protected active substances, which are made available through
the MPH group in the therapeutic areas oncology, HIV, rheumatology,
neurology and cardiovascular diseases, a contribution is made towards cost
reduction in the healthcare sector.
MPH Mittelständische Pharma Holding AG has been listed on the stock
exchange (Open Market) in Frankfurt.
Key capital market data for MPH Mittelständische Pharma Holding AG:
Subscribed Capital: EUR 38.050.000
Stock exchange listed class of shares: Owner held-preferred shares
Number of circulating preference shares: 19.025.000
ISIN: DE000A0NF697
WKN: A0NF69
Stock Exchange code: 93MV
Contact:
MPH Mittelständische Pharma Holding AG
Patricia Blechinger
Hubertusallee 73
14193 Berlin
Phone: +49 (0)30 897 308 660
Mail: ir(at)mph-ag.de
End of Corporate News
---------------------------------------------------------------------
31.08.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
137700 31.08.2011
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Great Panther Silver Ltd. erweitert hochgradige Silber-Gold-Mineralisierung und entdeckt neue Zone bei GuanajuatoDatum: 31.08.2011 - 13:18 Uhr
Sprache: Deutsch
News-ID 471155
Anzahl Zeichen: 3485
Kontakt-Informationen:
Kategorie:
Wirtschaft (allg.)
Diese Pressemitteilung wurde bisher 0 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MPH Mittelständische Pharma Holding AG:"
steht unter der journalistisch-redaktionellen Verantwortung von
MPH Mittelständische Pharma Holding AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).